DelMar's abstract "VAL-083, a novel N7 alkylating agent, surpasses temozolomide activity and inhibits cancer stem cells providing a new potential treatment option for glioblastoma multiforme" at Society for Neuro-Oncology (SNO) Annual Meeting 2012 Nov 1, 2012
DelMar's abstract "VAL083, a novel N7 alkylating agent, surpasses temozolomide activity and inhibits cancer stem cells providing a new potential treatment option for glioblastoma multiforme" at American Association of Cancer Research (AACR) Annual Meeting Apr 1, 2012
